• Features of metabolic and hormonal abnormalities in women with metabolic syndrome at the stage pregrada

Features of metabolic and hormonal abnormalities in women with metabolic syndrome at the stage pregrada

HEALTH OF WOMAN. 2017.4(120):57–61; doi 10.15574/HW.2017.120.57

Dyndar O. A.
A.A. Bogomolets National Medical University, Kiev

The problem of obesity and metabolic syndrome among the female population of Ukraine is extremely important, given the current trend toward increasing age of realization of reproductive function,. The prevalence of metabolic syndrome among women of reproductive age is 6–35%, fertility problems are found in 30-35% of women.

The objective: to study the characteristics of metabolic disorders and hormonal condition of the reproductive system in women with obesity and the metabolic syndrome on pregravidarity stage depending on the body mass index and severity of metabolic syndrome.

Patients and methods. We examined a total of 124 women with obesity and metabolic syndrome that appealed on pregravidar stage and 53 women who had no history of somatic and gynecological pathology. Antropometric studies, determination of blood pressure, examination of carbohydrate and lipid metabolism, evaluation of the endocrine status of the reproductive system, ultrasound examination of small pelvis organs were done.

Results. In women of reproductive age, we observed increase of total cholesterol, triglycerides, low-density lipoproteins and decrease high-density lipoproteins, with a predominance of IIb and IV types of dyslipidemia. Insulin resistance was diagnosed in 28.3% of women And 47.4% – II and in 69.7% with III degree of obesity. Metabolic syndrome was diagnosed in 79.2% of patients with obesity of I, in 94.7% – II 100% III. The number of components of metabolic syndrome correlate directly proportional to the severity of obesity. The index of fertility with III degree of obesity increased to 2.7, hypoestrogenia marked with And hyperestrogenia from 50.7% of women in II and III degree of obesity, progesterona failure identified at 66.9%, hyperandrogenism in 58.8%, reduced sex-binding globulin in 83.0% of the observations.

Conclusion. Pathological changes of the hormonal status of the female reproductive system on prepregnansy stage is directly proportional to depend on the body mass index number of components of metabolic syndrome and dysmetabolic disorders.

Key words: obesity, metabolic syndrome, pregnancy planning.


1. Andriets OA, Alexina NM, Andriets AV. 2013. The relationship between obesity and disorders of menstrual function in girls of prepubertal age. Pediatrics, obstetrics and gynecology 4:18-21.

2. Astakhov VM, Shelestova LP. 2012. Perinatal complications in women with alimentary obesity constitutionalism. Archiv of scientific articles of Association of obstetricians and gynecologists of Ukraine 1:191-193.

3. Benyuk VO, Dyndar OA, Grabowiy OM.  2012. Gystomorphological state of the placenta in preterm labor. Pediatrics, obstetrics and gynecology 2:67-69.

4. Ventskovskiy BM, Yarotskiy MYe, Tovstanovska VO. 2013. New approach to the prevention of placental insufficiency in women with obesity. Archiv of scientific articles of Association of obstetricians and gynecologists of Ukraine 1:87-88.

5. Voronenko NY. 2013. Metabolic syndrome and dysfunction of adipose tissue in women. Women's Health 5:65-71.

6. Gnatko OP, Marushchenko YuL. 2013. Development of preeclampsia in women with disorders of reproductive health on the background of metabolic syndrome. Women's Health 5:117.

7. Korchynska OO, Onysko AV, Tyshko MI. 2012. Role of adipokines in the occurrence of insulin resistance and impaired reproductive function in obese women. Clinical Pediatrics. 1-2(15-16):50-55.

8. Murray R, Grønner D, Maes P. 2003. The biochemistry of the human. in 2Vol. M., «Mir». I:540, II:525.

9. Despres JP, Nadeau A, Temblay A et al. 2013. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes. 38(3):304-309. https://doi.org/10.2337/diabetes.38.3.304; https://doi.org/10.2337/diab.38.3.304

10. Fendri S, Roussel B, Lormeau B. 2013. Insulin sensitivity, insulin action, and fibrinolysis activity in nondiabetic and diabetic obese subjects. Metabolism. Clinical & Experimental. 47(11):1372-1375. https://doi.org/10.1016/S0026-0495(98)90307-9